Pfizer Inc (PFE)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -27,642,000 | 16,368,000 | 3,390,000 | -5,395,000 | -5,052,000 |
| Revenue | US$ in thousands | 58,496,000 | 100,330,000 | 81,288,000 | 41,651,000 | 50,108,000 |
| Operating profit margin | -47.25% | 16.31% | 4.17% | -12.95% | -10.08% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-27,642,000K ÷ $58,496,000K
= -47.25%
The operating profit margin of Pfizer Inc. has exhibited variability over the past five years. In 2023, the operating profit margin decreased significantly to 5.74% from the previous year's high of 37.15% in 2022. This substantial decline may indicate challenges or changes in the company's operating efficiency or cost structure. However, it is important to note that the operating profit margin in 2023 remained positive despite the decrease.
Compared to 2021 and 2020, Pfizer's operating profit margin was higher in those years at 24.89% and 20.90%, respectively. The sharp decline from 2022 to 2023 suggests a potential shift in Pfizer's profitability dynamics which could be influenced by various factors such as changes in revenue, expenses, or one-time events.
In 2019, Pfizer had an operating profit margin of 26.90%, which was higher than the margins observed in 2021 and 2020 but lower than the exceptional margin in 2022. This indicates that Pfizer's operating profitability has fluctuated over the five-year period, possibly reflecting the evolving business environment and operational challenges faced by the company.
Overall, the downward trend in Pfizer's operating profit margin from 2022 to 2023 raises questions about the company's ability to maintain high levels of profitability in the future and may warrant further investigation into the underlying causes of this decline.
Peer comparison
Dec 31, 2023